Previous Close | 1.5500 |
Open | 1.6000 |
Bid | 1.6000 x 36100 |
Ask | 1.7600 x 43500 |
Day's Range | 1.6000 - 1.6700 |
52 Week Range | 1.1300 - 19.2250 |
Volume | |
Avg. Volume | 41,756 |
Market Cap | 1.365M |
Beta (5Y Monthly) | 1.07 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -56.5000 |
Earnings Date | Nov 12, 2024 - Nov 18, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 100.00 |
CHESTERBROOK, Pa., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that on October 4, 2024 the Company received notice that the Nasdaq Hearings Panel (the “Panel”) had determined to delist the Company’s common stock from The Nasdaq Stock Market LLC (“Nasdaq”) due to the Company’s failure to comply with the minimu
These are the upcoming stock splits for the week of August 12 to August 16, based on TipRanks’ Stock Splits Calendar. A stock split is a corporate action in which the company issues additional common shares to increase the number of outstanding shares. Accordingly, the stock price of the company’s shares decreases, which maintains the market capitalization before and after the split. In contrast, there are also reverse stock splits that reduce the number of outstanding shares (consolidate). In t